Source: Wikipedia, the free encyclopedia.
Chemical compound
Encainide |
|
| Trade names | Enkaid |
|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
|---|
| MedlinePlus | a605040 |
|---|
| ATC code | |
|---|
|
| Legal status |
|
|---|
|
|
JSmol) | |
|---|
|
InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25)  YKey:PJWPNDMDCLXCOM-UHFFFAOYSA-N Y
|
 NY (what is this?) (verify) |
Encainide (trade name Enkaid) is a class Ic
proarrhythmic side effects.
[1]Synthesis
Synthesis:[2]<
See also
References
VDCCsTooltip Voltage-dependent calcium channels
| |
|---|
VGKCsTooltip Voltage-gated potassium channels | |
|---|
IRKsTooltip Inwardly rectifying potassium channel | |
|---|
| KCaTooltip Calcium-activated potassium channel | |
|---|
K2PsTooltip Tandem pore domain potassium channel | |
|---|
VGSCsTooltip Voltage-gated sodium channels | |
|---|
| ENaCTooltip Epithelial sodium channel | |
|---|
| ASICsTooltip Acid-sensing ion channel | |
|---|
CaCCsTooltip Calcium-activated chloride channel | |
|---|
| CFTRTooltip Cystic fibrosis transmembrane conductance regulator | |
|---|
| Unsorted | |
|---|
| Others | | Tooltip Transient receptor potential channels | |
|---|
| Tooltip Ligand gated ion channels | |
|---|
|
|---|
|
N
Y (what is this?) (verify)